Web Analytics

Our publications:
Our publications

Bai Yong

Partner, Head of the antitrust practice in Greater China
Clifford Chance

Tel: +86 10 6535 2286
Email: yong.bai@cliffordchance.com

Practice areas

Competition & Antitrust; Telecommunications, Media and Technology; Outbound investment; Inbound investment


Bai Yong is a partner at Clifford Chance’s antitrust practice, heading its antitrust practice in Greater China. Before joining the firm, he worked for the Ministry of Commerce of the People’s Republic of China (MOFCOM). Bai is a member of the Expert Committee of the China Chamber of Commerce for Import and Export of Machinery and Electronic Products. He has unrivalled experience in and knowledge of the competition law landscape in China, with his MOFCOM experience, followed by more than 10 years of advising domestic and multinational corporations on antitrust and regulatory matters. Over the past couple of years, he has also worked in the firm’s London and Brussels offices, where he gained first-hand experience in competition law in these jurisdictions. As a result, Bai is one of the very few lawyers in the market able to give Chinese clients advice on global competition law issues from a Chinese perspective.

Bai covers a wide range of work and industry types, including high-profile global deals such as Pfizer’s USD160 billion merger with Allergan and GE’s USD21.4 billion disposal of its biopharma business to Danaher. He has also advised on inbound investment into China for multinational corporations such as Coca-Cola, GE, Henkel and Carrefour, and PE funds such as CVC, Partners Group, Permira and Affinity; the restructuring of Chinese state-owned enterprises such as the merger of Sinochem and ChemChina, the merger of China Shipbuilding Corporation and China Shipbuilding Industry Corporation, and China Baowu Steel Group’s acquisition of Magang Group and Taiyuan Iron and Steel Group, which all involved numerous filings across multiple jurisdictions; outbound deals by Chinese investors, such as COFCO’s acquisitions of Noble Agri and Nidera, which involved approximately 30 filings across multiple jurisdictions; antitrust investigations and leniency applications for clients in the pharmaceutical, logistics, technology and auto parts sectors; and compliance and regulatory work for regional and global clients.

Bai has been recognised by Chambers Asia-Pacific as a “Leading Individual”, Who’s Who Legal as a “Global Leader” and a “Future Leader”, and by The Legal 500 as a “Next Generation Partner”.

Tell others about this lawyer
Copy link

Join our mailing list for legal news and alerts

Sign up